Fresenius Medical (FMS) Gets FDA Nod for New Hemodialysis System

Fresenius Medical Care (FMS) recently announced the receipt of FDA 510(k) clearance for the company’s 5008X Hemodialysis System.The new system is aimed at providing an improved standard of care in dialysis therapy to patients suffering from kidney diseases in the United States. The FDA clearance will allow the company to start clinical evaluations and user studies in the United States.Price PerformanceFor the past six months, FMS’s shares have declined 24.0% against the industry’s growth of 6.0%. The S&P 50 ...